What is Geltor?
Headquartered in San Leandro, California, Geltor operates at the intersection of biotechnology and material science. The company specializes in the development of designer proteins that offer superior biocompatibility and functionality compared to traditional animal-derived counterparts. By utilizing a proprietary fermentation process, Geltor produces 100% animal-free ingredients that are clinically validated for high performance in sectors ranging from personal care to nutrition. This innovative approach addresses the growing consumer demand for sustainable, ethical, and high-quality alternatives in the supply chain, positioning Geltor as a critical player in the future of bio-based manufacturing.
How much funding has Geltor raised?
Geltor has raised a total of $109.5M across 2 funding rounds:
Series A
$18.2M
Series B
$91.3M
Series A (2018): $18.2M with participation from GELITA, ADM Ventures, BoxGroup, Cavallo Ventures, and Cultivian Sandbox Ventures
Series B (2020): $91.3M led by RIT Capital Partners, Blue Horizon Ventures, Humboldt Fund, Pegasus Tech Ventures, Cultivian Sandbox, SOSV, iSelect Fund Management, WTT Investment, and CPT Capital
Key Investors in Geltor
RIT Capital Partners
RIT Capital Partners is a London-based investment firm that manages a diversified portfolio, focusing on long-term capital growth through strategic investments in both public and private markets.
Cultivian Sandbox
Cultivian Sandbox Ventures specializes in food and agriculture technology, supporting companies that drive sustainability and innovation across the entire value chain.
SOSV
SOSV is a prominent multi-stage venture capital firm that provides both intellectual and financial resources to accelerate the growth of high-impact, technology-driven startups.
What's next for Geltor?
With the recent infusion of capital, Geltor is poised to scale its production capabilities and deepen its research and development initiatives. The strategic focus will likely center on optimizing manufacturing efficiencies to meet the increasing demand for its sustainable protein portfolio. Furthermore, the company is expected to leverage its strong investor network to explore new market verticals and enhance its competitive advantage in the rapidly evolving bio-design landscape. As Geltor continues to refine its technology, the focus remains on delivering scalable, high-performance solutions that redefine industry standards for sustainability and product efficacy.
See full Geltor company page
